Access to cystic fibrosis medication in South Africa secured

News Healthcare & Pharma Sanctions & Fines

Date: 11th Dec, 2024 Source: Competition Commission Country: South Africa Original Source

Brief

"On 11/12/2024, the Competition Commission issued an update regarding Access to cystic fibrosis medication in South Africa secured. The update details Vertex Pharmaceutical Incorporated's undertakings to make Trikafta available in South Africa through Section 21 of the Medicines and Related Substances Act, following a complaint initiated by the Commission for alleged exclusionary practices and excessive pricing."

This content is restricted.

Highlights content goes here...

This content is restricted.

Competition Commission

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Access to cystic fibrosis medication in South Africa secured

Brief

Competition Commission

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Access to cystic fibrosis medication in South Africa secured

Brief

Competition Commission

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.